empty cart | close cart

Your cart

Your cart is empty.

Get a quote close form

Tecan uses cookies to improve our website. By continuing to browse our website, you accept our cookie policy.

The Blog dot

Selected category: Oncology

Back to overview

Oncology prognostics: Why analyzing circulating cell free tumor DNA matters

By Nicholas Smith

We may well be on the threshold of a new hope for oncology. Shorthanded to ctDNA, circulating cell free tumor DNA is sloughed off from tumors. It can be detected in liquid biopsies of just a few milliliters of blood. This could revolutionize what oncology can achieve by diagnosing cancers earlier and more efficiently.

Read more

The short history of cancer research funding- Part II

By Martin Braendle
(Part 2 of 2. Read Part I). In 1948, Bill Koster of the Variety Club of New England and Dr. Sidney Farber working at the Children’s Hospital Boston had launched The Children's Cancer Research Fund, aimed at supporting a hospital dedicated to the research of childhood leukemia. But they needed a poster child to boost fundraising.

 
Read more